ELDORADO
ELDORADO: a Randomized Phase II Trial of Elranatamab or Daratumumab in Combination With Lenalidomide, Bortezomib, and Dexamethasone (RVd Lite) in Newly Diagnosed, Transplant Ineligible/Deferred Multiple Myeloma
Arms / Cohorts
Experimental:Daratumumab with lenalidomide, bortezomib, and dexamethasone (dara-RVd lite)
Not yet accepting
Experimental:Elranatamab with lenalidomide, bortezomib, and dexamethasone (elra-RVd lite)
Not yet accepting
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.